Report Overview
The Global Veterinary Biopsy Needles Market size is expected to be worth around US$ 744.1 Million by 2035 from US$ 341.5 Million in 2025, growing at a CAGR of 8.1% during the forecast period 2026-2035. In 2025, North America led the market, achieving over 38.4% share with a revenue of US$ 131.1 Million.
The global Veterinary Biopsy Needles Market is witnessing steady growth, driven by the increasing prevalence of animal diseases, rising pet ownership, and growing demand for advanced veterinary diagnostic procedures. Veterinary biopsy needles play a critical role in collecting tissue samples for the diagnosis of cancer, infections, and other chronic conditions in companion and livestock animals, enabling veterinarians to provide timely and accurate treatment.
The market is benefiting from advancements in veterinary healthcare infrastructure, increasing awareness regarding animal health, and the adoption of minimally invasive diagnostic techniques. Growing expenditure on pet healthcare, particularly in developed economies, is further supporting market expansion. Additionally, the rising focus on livestock health management and disease surveillance is creating new opportunities for manufacturers and healthcare providers.
Technological innovations, including improved needle designs, enhanced precision, and ultrasound-guided biopsy procedures, are contributing to better diagnostic outcomes and increased procedural efficiency. Market participants are also investing in product development and strategic collaborations to strengthen their market presence and address evolving customer needs.
North America currently dominates the veterinary biopsy needles market due to high pet adoption rates, well-established veterinary care systems, and significant spending on animal healthcare. Meanwhile, the Asia-Pacific region is expected to register the fastest growth during the forecast period, supported by expanding veterinary services, increasing livestock populations, and rising awareness of animal disease management.
Overall, the veterinary biopsy needles market is poised for sustained growth, supported by continuous advancements in veterinary diagnostics and growing emphasis on animal health worldwide.
Click here for more information: https://market.us/report/veterinary-biopsy-needles-market/
Key Takeaways
In 2025, the market generated a revenue of US$ 341.5 Million, with a CAGR of 8.1%, and is expected to reach US$ 744.1 Million by the year 2035.
The product segment is divided into aspiration biopsy needles, core biopsy needles, vacuum-assisted biopsy needles, bone biopsy needles, tissue biopsy needles and others, with core biopsy needles taking the lead with a market share of 46.8%.
Considering animal type, the market is divided into companion animals, livestock animals and others. Among these, companion animals held a significant share of 67.2%.
Furthermore, concerning the application segment, the market is segregated into tumor diagnosis, infectious disease diagnosis, inflammatory disease diagnosis, diagnostic, therapeutic and research. The tumor diagnosis sector stands out as the dominant player, holding the largest revenue share of 48.3% in the market.
The end-user segment is segregated into veterinary hospitals, veterinary clinics, research institutes and others, with the veterinary hospitals segment leading the market, holding a revenue share of 56.0%.
North America led the market by securing a market share of 38.4%.
Key Market Segments
By Product
Aspiration Biopsy Needles
Core Biopsy Needles
Vacuum-Assisted Biopsy Needles
Bone Biopsy Needles
Tissue Biopsy Needles
Others
By Animal Type
Companion Animals
Livestock Animals
Others
By Application
Tumor Diagnosis
Infectious Disease Diagnosis
Inflammatory Disease Diagnosis
Diagnostic
Therapeutic
Research
By End-User
Veterinary Hospitals
Veterinary Clinics
Research Institutes
Top Key Players
Medtronic plc
Becton, Dickinson and Company (BD)
Jorgensen Laboratories
Argon Medical Devices, Inc.
Olympus Corporation
Jrgen Kruuse A/S
Surgivet
Vygon Vet
B. Braun Melsungen AG
Cook Group
Merit Medical Systems
KARL STORZ
Emerging Trends in the Veterinary Biopsy Needles Market
Rising cancer diagnosis in companion animals: Veterinary clinics are increasingly using biopsy needles for early cancer detection in dogs and cats. The 2024 AVMA pet ownership survey was based on responses from more than 14,500 households, reflecting growing demand for advanced diagnostic services and tissue-sampling procedures in companion animal care.
Growth in livestock disease surveillance: Governments are strengthening animal disease monitoring programs. The USDA reported 94.2 million cattle and calves in the U.S. in 2025, creating substantial demand for biopsy-based diagnostics to investigate infections, tumors, and unexplained health conditions in large livestock populations.
Increased use of image-guided biopsies: Veterinarians are increasingly combining ultrasound and imaging technologies with biopsy needles. Image-guided procedures improve sample accuracy, reduce repeat testing, and support minimally invasive diagnostics, particularly for deep-tissue lesions in companion and farm animals. This trend is improving diagnostic confidence and treatment planning.
Greater focus on outbreak preparedness: Recent disease events in dairy cattle have increased emphasis on rapid diagnostic tools. USDA data show avian influenza infections have been identified in dairy cattle across multiple states, encouraging veterinary facilities to adopt advanced tissue-sampling and disease investigation techniques.
Expansion of precision livestock healthcare: Animal health monitoring is becoming more data-driven. Research involving 200 dairy cows achieved 96.1% behavioral recognition accuracy using AI-based monitoring, supporting broader adoption of precision veterinary diagnostics, including targeted biopsy procedures for disease confirmation and herd health management.
Key Use Cases of Veterinary Biopsy Needles
Cancer and tumor diagnosis: Biopsy needles are widely used to collect tissue samples from suspected tumors in dogs, cats, and horses. Histopathological examination helps veterinarians identify cancer type, stage disease progression, and determine appropriate treatment strategies, improving clinical decision-making and patient outcomes.
Investigation of infectious diseases: Veterinarians use biopsy needles to obtain tissue samples from infected organs or lesions. Laboratory analysis helps identify bacterial, viral, fungal, or parasitic infections, enabling targeted treatment and reducing the risk of disease spread within animal populations.
Liver and kidney disease assessment: Biopsy procedures support diagnosis of chronic liver and kidney disorders. Tissue examination provides information about inflammation, fibrosis, and organ damage, helping veterinarians develop accurate treatment plans and monitor disease progression in companion animals and livestock.
Livestock herd health management: In cattle populations exceeding 94 million head in the U.S., biopsy needles are used to investigate unexplained illness, production losses, and disease outbreaks. Accurate diagnosis helps farmers improve herd productivity, biosecurity measures, and overall animal health management.
Research and veterinary education: Veterinary universities, research institutes, and diagnostic laboratories use biopsy needles for pathology studies and disease surveillance programs. Tissue samples support research on emerging animal diseases, treatment effectiveness, and the development of advanced veterinary diagnostic technologies.
Conclusion: the veterinary biopsy needles market is evolving steadily as animal healthcare providers place greater emphasis on early and accurate disease diagnosis. Growing pet ownership, increasing livestock populations, and rising awareness of animal health are driving the adoption of biopsy-based diagnostic procedures. Technological advancements such as image-guided biopsies and precision veterinary medicine are improving diagnostic accuracy and procedural efficiency. Additionally, the need for effective disease surveillance and outbreak management continues to strengthen demand across both companion animal and livestock sectors. As veterinary diagnostics become more advanced, biopsy needles will remain an essential tool for supporting better animal health outcomes worldwide.
Top comments (0)